Bedrocan Danmark ApS: Financial statements 2024
CVR: 43238779
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Bedrocan Danmark ApS (CVR 43238779) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 44,176,363 and a net result of DKK 10,182,909 compared with DKK -13,867,739 the year before. Equity in the 2024 report amounted to DKK 103,737,052. The solvency ratio was 47.2%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 44,176,363
- Profit/Loss
- DKK 10,182,909
- Equity
- DKK 103,737,052
- Total Assets
- DKK 219,830,105
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 44.2 mio. | 10.2 mio. | 103.7 mio. | 10 |
| 2023 | - | -2.6 mio. | -13.9 mio. | 41.3 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Bedrocan Danmark ApS has published its annual report for 2023. Gross profit came to DKK -2,599,674, and the net result was DKK -13,867,739.
About Bedrocan Danmark ApS
Bedrocan Danmark ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2022. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Jacob Leendert Erkelens and Hans Rudolf Spits. The company is owned by Bedrocan International B.V.. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK 36,432,443 and a net result of DKK 777,337 compared with DKK 10,182,909 the year before. Equity in the 2025 report amounted to DKK 104,514,389.